Creon - 0032-3016-28 - (Pancrelipase)

Alphabetical Index


Drug Information of Creon

Product NDC: 0032-3016
Proprietary Name: Creon
Non Proprietary Name: Pancrelipase
Active Ingredient(s): 180000; 36000; 114000    [USP'U]/1; [USP'U]/1; [USP'U]/1 & nbsp;   Pancrelipase
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE PELLETS
Coding System: National Drug Codes(NDC)

Labeler Information of Creon

Product NDC: 0032-3016
Labeler Name: AbbVie Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020725
Marketing Category: NDA
Start Marketing Date: 20130104

Package Information of Creon

Package NDC: 0032-3016-28
Package Description: 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-3016-28)

NDC Information of Creon

NDC Code 0032-3016-28
Proprietary Name Creon
Package Description 250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-3016-28)
Product NDC 0032-3016
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Pancrelipase
Dosage Form Name CAPSULE, DELAYED RELEASE PELLETS
Route Name ORAL
Start Marketing Date 20130104
Marketing Category Name NDA
Labeler Name AbbVie Inc.
Substance Name PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
Strength Number 180000; 36000; 114000
Strength Unit [USP'U]/1; [USP'U]/1; [USP'U]/1
Pharmaceutical Classes

Complete Information of Creon


General Information